This document revises the OECD's statistical definition of biotechnology, which had last been reviewed in 2008, and proposes the adoption of a statistical definition of nanotechnology in the same format.
This report identifies, and seeks to address, key challenges for the responsible development of neurotechnology. In particular, it analyses frameworks and mechanisms for integrating social concerns in the early development of technology, and discusses best practices for research funders across the public and private sector.
Several countries have been setting up strategic roadmaps to support marine biotechnologies that could drive innovation and help address the global sustainability goals of food, energy, and health. This report identifies and begins to address challenges facing cooperation on marine biotechnology across countries.
There is now strong evidence that microbiomes play an important role in human health, as there are clear linkages to many major non-communicable diseases. This report assesses the key policy challenges for innovation in the microbiome. It argues that if such a promising scientific field is to lead to innovative applications, policies on science and innovation must be improved in five areas.
A December 2015 workshop in Lausanne reviewed the policy and stakeholder actions needed to accelerate biomedical research and health innovation for Alzheimer’s disease and other dementias. There is consensus across all stakeholders to move from global agenda setting in Alzheimer’s disease to action oriented programmes and implementation.
Accelerating innovation for Alzheimer’s disease and other dementias is a key challenge. An OECD workshop in November 2014 provided an international forum for all stakeholders to drive forward a change in the global paradigm in biomedical research and health innovation for Alzheimer’s disease and other dementias.
This report looks at the roles and options of stakeholders (governments, regulatory agencies, academia, small and mid-size biotech companies, the pharmaceutical industry, and patient organisations) in public-private partnerships for product development in Alzheimer’s disease and other dementias.
This report explores the characteristics of nanotechnology as it relates to technology convergence i.e. actual instances of the convergence of different technology streams in the research and innovation environments within laboratories and companies. It examines four application areas in which nanotechnology plays a strong role (green packaging, food safety and security, pharmaceuticals and medical devices).
Several OECD countries have published their plans for the development of a future bioeconomy, in which bio-based materials and production techniques will contribute significantly to economic and environmental sustainability. The case for support for bio-based chemicals and plastics therefore warrants serious attention.
Synthetic biology is an emerging technology that shows promise for investigating some of the burning issues in biological research. It also has the potential to address some of the grand challenges facing society, such as climate change and energy security.